Major Players Include Johnson & Johnson, Novartis, Hoffmann-La Roche, Novo Nordisk and Bayer
DUBLIN, May 16, 2023 /PRNewswire/ — The “Bi-Specific MAbS Global Market Report 2023” report has been added to ResearchAndMarkets.com’s offering. This report provides strategists, marketers and senior management with the critical information they need to assess the market. The global bi-specific mabs market is expected to grow from $3.80 billion in 2021 to $5.13 billion … Read more